The biotechnology R&D intensity in Poland's business sector has experienced substantial fluctuations over the past decade. From 2013 to 2015, the sector saw significant increase and decline, with a marked peak in 2014 at 50.67% year-on-year growth and a notable drop in 2016 by -48.09%. The subsequent years stabilized somewhat, exhibiting both positive and negative variations. Recent years display a less volatile trend, with the 2023 value standing at 2.17, representing a modest 1.1% year-on-year increase and a CAGR of -3.04% over the last five years.
Looking ahead, the forecasted data from 2024 to 2028 suggest a slight upward trend in biotechnology R&D intensity, with a forecasted 5-year CAGR of 0.4% and an overall growth rate of 2.04%. This suggests a period of moderate growth, signaling a potential stabilization and gradual improvement in R&D investments in the sector.
Future trends to watch for include the impact of governmental policies on biotech R&D funding, the influence of global biotech advances on local research priorities, and potential private sector investments driving further growth in this sector.
